Merit Medical Systems Stock Hits New 52-Week High (MMSI)
Merit Medical Systems (Nasdaq:MMSI) hit a new 52-week high Friday as it changed hands at $19.90 compared with its previous 52-week high of $19.84. Merit Medical Systems is currently trading at $19.87 with 70,603 shares changing hands as of 11:47 a.m.
NEW YORK ( TheStreet) -- Merit Medical Systems (Nasdaq: MMSI) hit a new 52-week high Friday as it traded at $19.90 compared with its previous 52-Week high of $19.84. Merit Medical Systems is changing hands at $19.87 with 70,603 shares traded as of 11:47 a.m. ET. Average volume has been 171,100 shares over the past 30 days. Merit Medical Systems has a market cap of $543.7 million and is part of the health care sector and health services industry. Shares are up 23.6% year to date as of the close of trading on Thursday. Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional and diagnostic procedures worldwide. The company's cardiology and radiology products include percutaneous coronary interventions and percutaneous peripheral interventions. The company has a P/E ratio of 44.4, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 16.
Practice your MMSI trading strategies and win cash in our stock game.
TheStreet Ratings rates Merit Medical Systems as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. You can view the full Merit Medical Systems Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center.